Fuller & Thaler Asset Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,574,860
Closed -$8.87M 533
2023
Q3
$8.87M Buy
+1,574,860
New +$10.5M 0.05% 263

Other funds holding GDRX

Fuller & Thaler Asset Management's GDRX Position: Q4 2023 in Review

Fuller & Thaler Asset Management sold out of GoodRx Holdings (GDRX) in Q4 2023, closing a stake of 1,574,860 shares — an estimated $8.87M sold.

Fuller & Thaler Asset Management first reported a position in GDRX in Q3 2023 and held it in 1 quarter. The position peaked at $8.87M in Q3 2023. 143 funds tracked by Wall St. Rank hold GDRX as of Q4 2023.

  • Fuller & Thaler Asset Management reported no remaining GoodRx Holdings position as of Q4 2023 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 1,574,860 GoodRx Holdings shares in Q4 2023, an estimated $8.87M.
  • Fuller & Thaler Asset Management first reported a position in GoodRx Holdings in Q3 2023 and held it in 1 quarter.
  • Fuller & Thaler Asset Management's GoodRx Holdings position peaked at $8.87M in Q3 2023.
  • 143 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2023.

Based on Fuller & Thaler Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.